Company · CIK 1894562

# Prime Medicine, Inc.

| CIK | [1894562](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001894562) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | PRME (Nasdaq) |
| First annual or quarterly report | 2022-11-14 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-291348 | Shelf Effective | 2025-11-07 | 2026-03-04 | 2 |
| 333-275321 | Shelf Effective | 2023-11-03 | 2025-07-31 | 6 |
| 333-283780 | Shelf Effective | 2024-12-13 | 2024-12-20 | 2 |
| 333-267579 | IPO Final prospectus | 2022-09-23 | 2022-10-21 | 5 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894562/999999999526000723/9999999995-26-000723-index.htm) Declared effective | 333-291348 | 9999999995-26-000723 |
| 2025-11-07 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1894562/000162828025050428/0001628280-25-050428-index.htm) Shelf registered | 333-291348 | 0001628280-25-050428 |
| 2025-07-31 | [424B5](https://www.sec.gov/Archives/edgar/data/1894562/000162828025037072/0001628280-25-037072-index.htm) Shelf takedown | 333-275321 | 0001628280-25-037072 |
| 2025-07-30 | [424B5](https://www.sec.gov/Archives/edgar/data/1894562/000162828025036721/0001628280-25-036721-index.htm) Shelf takedown | 333-275321 | 0001628280-25-036721 |
| 2024-12-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894562/999999999524003900/9999999995-24-003900-index.htm) Declared effective | 333-283780 | 9999999995-24-003900 |
| 2024-12-13 | [S-3](https://www.sec.gov/Archives/edgar/data/1894562/000162828024051126/0001628280-24-051126-index.htm) Shelf registered | 333-283780 | 0001628280-24-051126 |
| 2024-02-16 | [424B5](https://www.sec.gov/Archives/edgar/data/1894562/000162828024005201/0001628280-24-005201-index.htm) Shelf takedown | 333-275321 | 0001628280-24-005201 |
| 2024-02-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1894562/000162828024004859/0001628280-24-004859-index.htm) Shelf takedown | 333-275321 | 0001628280-24-004859 |
| 2023-11-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894562/999999999523003310/9999999995-23-003310-index.htm) Declared effective | 333-275321 | 9999999995-23-003310 |
| 2023-11-03 | [S-3](https://www.sec.gov/Archives/edgar/data/1894562/000162828023036792/0001628280-23-036792-index.htm) Shelf registered | 333-275321 | 0001628280-23-036792 |
| 2022-10-21 | [424B4](https://www.sec.gov/Archives/edgar/data/1894562/000162828022026826/0001628280-22-026826-index.htm) Final prospectus | 333-267579 | 0001628280-22-026826 |
| 2022-10-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1894562/999999999522003086/9999999995-22-003086-index.htm) Declared effective | 333-267579 | 9999999995-22-003086 |
| 2022-10-17 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894562/000162828022026491/0001628280-22-026491-index.htm) Amendment | 333-267579 | 0001628280-22-026491 |
| 2022-10-13 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1894562/000162828022026329/0001628280-22-026329-index.htm) Amendment | 333-267579 | 0001628280-22-026329 |
| 2022-09-23 | [S-1](https://www.sec.gov/Archives/edgar/data/1894562/000162828022025424/0001628280-22-025424-index.htm) Registration filed | 333-267579 | 0001628280-22-025424 |
| 2021-12-20 | [DRS](https://www.sec.gov/Archives/edgar/data/1894562/000162827921000794/0001628279-21-000794-index.htm) Draft made public | 377-05831 | 0001628279-21-000794 |

[All filings of this company](https://equitycapital.markets/filings?cik=1894562) · [CSV](https://equitycapital.markets/filings.csv?cik=1894562)

---
Source page: https://equitycapital.markets/company/1894562 · Data: U.S. SEC EDGAR · CC BY 4.0